Financial statements Prorodent
Balance sheet of Prorodent
Company age:
Age:
3 y. 6 m. 15 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of PRORODENT
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 506 577,05 | 371 248,06 |
| A. Fixed assets | 256 447,67 | 0,00 |
| B. Current assets | 250 129,38 | 63 823,29 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 506 577,05 | 1 367 493,38 |
| A. Equity | 359 120,34 | 26 489,77 |
| B. Liabilities and provisions for liabilities | 147 456,71 | 344 758,29 |
| I. Long-term liabilities | 97 461,00 | 155 017,69 |
| II. Short-term liabilities | 49 995,71 | 189 740,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.